Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: J Clin Pathol. 2019 Jun 24;72(12):825–829. doi: 10.1136/jclinpath-2019-205700

Figure 1. Comparison of serum values for PG1 (a) and TFF3 (b).

Figure 1

Displayed is the distribution of serum values for PG1 (a) and TFF3 (b) for individuals with non-dysplastic Barrett’s oesophagus (NDBE), more advanced oesophageal lesions, including high grade dysplasia and intramucosal cancer (HGD/IMC) and non-Barrett’s “controls”. Group comparison was done by Kruskal-Wallis test with significance being assumed for p<0.05.